THE RELATIONSHIP BETWEEN SERUM HOMOCYSTEINE LEVEL AND INSULIN RESISTANCE LEVEL IN WOMEN WITH POLYCYSTIC OVARIAN SYNDROME AND RECURRENT PREGNANCY LOSS

Authors
  • Sarah Sarmed Manea

    Maternal and Child Hospital, Basrah, Iraq
  • Sarah Sarmed Manea

    Maternal and Child Hospital, Basrah, Iraq
  • Sharief M

    Department of Gynecology and Obstetrics, College of Medicine, University of Basrah, Basrah, Iraq
Keywords:
Homocysteine, Insulin resistance, Miscarriage, Polycystic ovarian syndrome
Abstract
Introduction: Women with polycystic ovarian syndrome (PCOS) who experience spontaneous miscarriages may have high levels of homocysteine (Hcy). It has been proposed that this connection might be a significant feature of PCOS. Aim: To evaluate the association between elevated serum homocysteine level and insulin resistance in PCOS patients who have a history of recurrent miscarriages. Materials and Methods: This prospective study was performed at Basrah Maternity Hospital between 1st of May 2022 till the 1st of June 2024. 124 women were included in the study. 68 women diagnosed as PCOS with history of 2 or more recurrent miscarriages. PCOS was diagnosed based on Rotterdam criteria. In addition to estimation of homocysteine and Insulin Resistance with serum level of FSH, LH, Testosterone and DHEA in both groups. Results: The age of women in the sample ranged between 28.9± 4.28 and 29.85 ± 3.69 years; most of the women had BMI between 24.79 ±2.21.and 34.71±3.45. There was no statistical difference in both groups with regard to age and number of Miscarriages but there was significant difference in relation to BMI. Moreover, there was a significant difference in regard to insulin level, insulin resistance and the level of homocysteine in PCOS which were higher than the control group. Conclusion: Insulin resistance and hyperinsulinaemia in patients with PCOS is associated with elevated plasma homocystiene with regard to BMI which may have important implications in the short term regarding reproductive performance.
References

1. Ding DC, Chen W, Wang JH, Lin SZ. Association between polycystic ovarian syndrome and endometrial, ovarian, and breast cancer: A population-based cohort study in Taiwan. Medicine (Baltimore). 2018 ;97(39):e12608. doi: 10.1097/MD.0000000000012608.

2. Norman RJ, Teede HJ. A new evidence-based guideline for assessment and management of polycystic ovary syndrome. Med J Aust. 2018;209(7):299-300. doi: 10.5694/mja18.00635.

3. Cao C, Bai S, Zhang J, Sun X, Meng A, Chen H. Understanding recurrent pregnancy loss: recent advances on its etiology, clinical diagnosis, and management. Med Rev (2021). 2022; 2(6):570-589.

4. Son P, Lewis L. Hyperhomocysteinemia. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024. Available from: https://www.ncbi.nlm.nih.gov/books/NBK554408/

5. Laskowska M, Laskowska K, Terbosh M, Oleszczuk J. A comparison of maternal serum levels of endothelial nitric oxide synthase, asymmetric dimethylarginine, and homocysteine in normal and preeclamptic pregnancies. Med Sci Monit. 2013; 19:430-7. doi: 10.12659/MSM.883932.

6. Yarali, Tmoglu M, Unal O, Turan C. Chronic inflammation and elevated homocysteine levels are associated with increased body mass index in women with polycystic ovary syndrome. Gynecol Endocrinol. 2007;23(9):505–510. [PubMed] [Google Scholar]

7. Bhushan R, Sinha P. Correlation of Serum Homocysteine Levels and Hyperinsulinaemia with Body Mass Index in Polycystic Ovarian Syndrome. J Hum Reprod Sci. 2022; 15(1):34-41. doi: 10.4103/jhrs.jhrs_147_21.

8. Wartena R, Matjila M. Polycystic ovary syndrome and recurrent pregnancy loss, a review of literature. Front Endocrinol (Lausanne). 2023; 14:1183060. doi: 10.3389/fendo.2023.1183060.

9. Freeman AM, Acevedo LA, Pennings N. Insulin Resistance. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024. Available in :https://www.ncbi.nlm.nih.gov/books/NBK507839/

10. Zhao H, Zhang J, Cheng X, Nie X, He B. Insulin resistance in polycystic ovary syndrome across various tissues: an updated review of pathogenesis, evaluation, and treatment. J Ovarian Res. 2023; 16(1):9. doi: 10.1186/s13048-022-01091-0.

11. Kondapaneni V, Gutlapalli SD, Poudel S, Zeb M, Toulassi IA, Cancarevic I. Significance of Homocysteine Levels in the Management of Polycystic Ovarian Syndrome: A Literature Review. Cureus. 2020; 12(10): e11110. doi: 10.7759/cureus.11110.

12. Tarcau BM, Negru A, Ghitea TC, Marian E. Is There a Connection between Hyperhomocysteinemia and the Cardiometabolic Syndrome? Biomedicines. 2024; 12(6):1135. https://doi.org/10.3390/biomedicines12061135

13. Hemati T, Moghadami-Tabrizi N, Davari-Tanha F, Salmanian B, Javadian P. High plasma homocysteine and insulin resistance in patients with polycystic ovarian syndrome. Iran J Reprod Med. 2011 Summer;9(3):223-8. https://pubmed.ncbi.nlm.nih.gov/26396568/

14. Szczesnowicz A, Szeliga A, Niwczyk O, Bala G, Meczekalski B. Do GLP-1 Analogs Have a Place in the Treatment of PCOS? New Insights and Promising Therapies. J Clin Med. 2023;12(18):5915.

15. Sills Welch GN, Loscalzo J. Homocysteine and atherothrombosis. N Engl J Med. 1998;338(15):1042–1050. [PubMed] [Google Scholar

16. Meng Y, Chen X, Peng Z, Liu X, Sun Y, Dai S. Association between High Serum Homocysteine Levels and Biochemical Characteristics in Women with Polycystic Ovarian Syndrome: A Systematic Review and Meta-Analysis. PLoS One. 2016;11(6): e0157389. doi: 10.1371/journal.pone.0157389.

17. Razi Y, Eftekhar M, Fesahat F, Dehghani Firouzabadi R, Razi N, Sabour M, Razi MH. Concentrations of homocysteine in follicular fluid and embryo quality and oocyte maturity in infertile women: a prospective cohort. J Obstet Gynaecol. 2021;41(4):588-593. doi: 10.1080/01443615.2020.1785409.

18. Practice Committee of the American Society for Reproductive Medicine. Electronic address: asrm@asrm.org. Definitions of infertility and recurrent pregnancy loss: a committee opinion. Fertil Steril. 2020;113(3):533-535. doi: 10.1016/j.fertnstert.2019.11.025.

19. Asanidze E, Kristesashvili J, Andguladze S. Corelation between levels of homocysteine, anti-mullerian hormone and insulin resistance in PCOS patients with recurrent miscarriage. Georgian Med News. 2019;(290):25-29.

20. Wijeyaratne et. al. Insulin secretion as a potential determinant of homocysteine levels. Med Hypotheses. 2000;55(5):454–455. [PubMed] [Google Scholar}.

21. Li JC, Feigenbaum SL, Yang J, Pressman AR, Selby JV, Go AS. Epidemiology and adverse cardiovascular risk profile of diagnosed polycystic ovary syndrome. J Clin Endocrinol Metab. 2020;91(4):1357–1363.

22. Loverro G, Lorusso F, Mei L, Depalo R, Cormio G, Selvaggi L. The plasma homocysteine levels are increased in polycystic ovary syndrome. Gynecol Obstet Invest. 2002;53(3):157–162. [PubMed] [Google Scholar]